Kate Lindborg

Dr. Lindborg joined Imricor in 2020 and is responsible for developing the company’s clinical strategy and leading preclinical and clinical investigations.

Dr. Lindborg has over 12 years of experience in the medical device industry primarily focused on clinical study development, execution, and evidence generation.

Prior to joining the Company, Dr Lindborg held various roles within Medtronic’s Cardiac Rhythm and Heart Failure and Diagnostics Clinical organizations. Dr Lindborg’s roles included leading pre and post-market clinical investigations, managing evidence generation, and clinical strategy development to gain and maintain market approval of novel devices.

Dr Lindborg holds a Doctor of Philosophy and Master of Science in Physiological Sciences from the University of Arizona as well as a Bachelor of Arts from Gustavus Adolphus College.